EchoIQ LimitedASX: EIQ

EchoSolv HF regulatory update

· Issued by EchoIQ Limited

Filed with ASX · · 1 page · English

Summary by 6ix AI

Echo IQ Limited provides a regulatory update regarding EchoSolv HF, stating that the FDA has upheld its previous determination of 'not substantially equivalent' for the product. The company is exploring options with its regulatory and legal advisors, including a potential new submission to the FDA. Echo IQ emphasizes that this decision does not impact EchoSolv AS, which remains FDA-cleared and available in the US. The company will continue to inform the market in line with its disclosure obligations.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

EchoIQ Limited on 6ix

Earlier from EchoIQ

Later from EchoIQ

All EchoIQ news releases